These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7157162)

  • 1. [Pharmacodynamic aspects of obzidan in chronic ischemic heart disease].
    Zaĭtseva VI; Dorogoĭ AP
    Ter Arkh; 1982; 54(11):123-8. PubMed ID: 7157162
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined obzidan and verapamil treatment of ischemic heart disease patients].
    Furkalo NK; Zaĭtseva VI
    Ter Arkh; 1987; 59(9):120-2. PubMed ID: 3424175
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of propranolol and verapamil in patients with ischemic heart disease].
    Chizh VD
    Vrach Delo; 1990 Feb; (2):15-8. PubMed ID: 2339541
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of physical work capacity of patients with chronic ischemic heart disease during treatment with inderal].
    Zadiunchenko VS; Pomerantsev VP; Mikheev AI; Vertkin AL
    Sov Med; 1975 Apr; (4):19-23. PubMed ID: 1188452
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of anaprilin on the contractile and pump functions of the left ventricle in elderly patients with chronic ischemic heart disease].
    Ivanov IA
    Vrach Delo; 1984 Feb; (2):40-3. PubMed ID: 6719868
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sympathetic-adrenal system in ischemic heart disease before and after obzidan treatment].
    Orlov VN; Chigrinova LS
    Klin Med (Mosk); 1981 Jun; 59(6):74-8. PubMed ID: 6116820
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of obzidan on the function of endocrine glands regulating calcium metabolism in patients with ischemic heart disease].
    Zoloev GK; Borisova EV; Slepushkin VD
    Klin Med (Mosk); 1986 Jan; 64(1):60-3. PubMed ID: 3959519
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of propranolol on myocardial contractility and on ventricular repolarization in patients with electrocardiographic changes of ischemic type and without heart insufficiency detectable by Valsalva's index].
    Reyes AJ; Isasi EJ
    Rev Esp Cardiol; 1971; 24(4):429-35. PubMed ID: 5156547
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemodynamic assessment of anti-angina preparations in treating patients with ischemic heart disease with hypertension].
    Iunusov RA; Burykh LN; Sviridova NI
    Vrach Delo; 1987 Aug; (8):25-7. PubMed ID: 3686955
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of obzidan in continuous cardiac fibrillation and extrasystole in middle-aged and elderly patients with ischemic heart disease].
    Korkushko OV; Butenko AG
    Klin Med (Mosk); 1983 Nov; 61(11):34-40. PubMed ID: 6198556
    [No Abstract]   [Full Text] [Related]  

  • 11. [Proceedings: Exercise plethysmography in patients with ischemic heart diseases--the effect of propranolol].
    Yasue H; Tanaka A; Morita M
    Jpn Circ J; 1975 Apr; 39(4):505. PubMed ID: 1121117
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of propranolol on the electrocardiographic changes of the ischemic type].
    Pesola A; L'Abbate A; Pentimone F; Giusti C
    Cuore Circ; 1968 Jun; 52(3):135-45. PubMed ID: 5740597
    [No Abstract]   [Full Text] [Related]  

  • 13. [Morphological criteria of the effectiveness of using kordaron and obzidan in experimental myocardial ischemia].
    Grigor'eva NN; Gichka SG; Stepaniuk GI; Degtiareva LV
    Vrach Delo; 1984 Oct; (10):91-3. PubMed ID: 6516320
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative evaluation of nifedipine and propranolol in ischemic heart disease].
    Kukes VG; Al'perovich BR; Rumiantsev AS
    Sov Med; 1986; (1):65-8. PubMed ID: 3961570
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative studies of L- as well as DL-oxyfedrine in healthy people and patients with chronic ischemic heart diseases].
    Teichmann W; Lukesch KH; Rikirsch P; Schäbitz J; Schmidt GA; Vogel HC; Sziegoleit W; Enke H
    Z Arztl Fortbild (Jena); 1976 May; 70(10):554-9. PubMed ID: 782052
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of riboxin in treating patients with chronic ischemic heart disease].
    Lanovaia NI; Neĭko EM
    Vrach Delo; 1986 Aug; (8):17-9. PubMed ID: 3776150
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative effectiveness of inderal and trazikor in the treatment of chronic ischemic heart disease].
    Ermilov LP; Safronnikov LV; Kuleshova EV
    Klin Med (Mosk); 1977; 55(1):21-5. PubMed ID: 839688
    [No Abstract]   [Full Text] [Related]  

  • 18. [Activity of the sympathetic-adrenal system in ischemic heart disease during treatment with obsidan].
    Orlov VN; Chigrinova LS
    Sov Med; 1981; (1):21-6. PubMed ID: 7244775
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relationship between the activity of sympathico-adrenal system and clinico-physiological parameters in patients with ischemic heart disease during inderal therapy].
    Orlov VN; Chigrinova LS
    Ter Arkh; 1982; 54(5):53-7. PubMed ID: 7115506
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic effect of obzidan and its influence on the hemodynamics of hypertension patients].
    Charyev KhE; Erina EV; Iurenev AP
    Ter Arkh; 1984; 56(4):79-83. PubMed ID: 6729736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.